Trial Profile
A clinical trial of zinc monocysteine in combination with copper in patients with amyotrophic lateral sclerosis.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2011
Price :
$35
*
At a glance
- Drugs Zinc monocysteine (Primary) ; Copper
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; Therapeutic Use
- 03 Oct 2011 New trial record